Editors’ Picks: August Highlights from the AACR Journals
This month, the editors of the AACR’s journals have decided to feature a clinical trial evaluating prolonged treatment with ibrutinib for patients with chronic...
Category: Journals
This month, the editors of the AACR’s journals have decided to feature a clinical trial evaluating prolonged treatment with ibrutinib for patients with chronic...
As the murders of George Floyd, Breonna Taylor, and others exposed racial inequities in America, many sectors of society...
This month, the editors of the AACR’s journals have chosen to highlight an analysis of birth characteristics and risk...
Every month, the editors from the portfolio of scientific journals published by the AACR select one “must read” article...
In the United States, nearly 24,000 people are estimated to receive a brain or nervous system cancer diagnosis in 2020....
The excitement surrounding this week’s AACR Virtual Meeting I – which drew more than 61,000 people on the first day – can’t stop us from delivering the latest edition of Editors’...
February is drawing to a close, and it’s time for our monthly staple: the collection of 10 “must read”...
Back for the new decade is our regular staple: the monthly collection of 10 “must read” articles that have...
The first new anticancer therapeutics approved by the U.S. Food and Drug Administration (FDA) in 2020 are for the...
The first paper to be accepted by the AACR’s latest journal, Blood Cancer Discovery, was published online last week....